DexCom
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1,113,500 | $994,200 | $1,004,300 | $921,000 |
Gross Profit | 654,000 | 593,800 | 626,700 | 561,900 |
EBITDA | 242,400 | 237,400 | 244,700 | 189,600 |
EBIT | 187,100 | 182,100 | 192,600 | 137,100 |
Net Income | 151,700 | 134,600 | 143,500 | 146,400 |
Net Change In Cash | 1,113,500 | 994,200 | 1,004,300 | 921,000 |
Free Cash Flow | 176,800 | 88,300 | 213,300 | 152,300 |
Cash | 606,100 | 621,200 | 939,200 | 851,200 |
Basic Shares | 406,700 | 410,200 | 416,800 | 416,700 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $4,033,000 | $3,622,300 | $2,909,800 | $2,448,500 |
Gross Profit | 2,465,700 | 2,288,900 | 1,883,100 | 1,680,500 |
EBITDA | 840,699 | 916,700 | 565,300 | 377,500 |
EBIT | 622,999 | 730,700 | 409,400 | 275,600 |
Net Income | 576,200 | 541,500 | 341,200 | 154,700 |
Net Change In Cash | 4,033,000 | 3,622,300 | 2,909,800 | 2,448,500 |
Cost of Revenue | -404,500 | 236,800 | ||
Free Cash Flow | 630,700 | 511,900 | 304,700 | 53,300 |
Cash | 606,100 | 566,300 | 642,300 | 1,052,600 |
Basic Shares | 412,700 | 425,500 | 427,500 | 428,800 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.45 |
2024-09-30 | $0.45 |
2024-06-30 | $0.43 |
2024-03-31 | $0.32 |
